Zobrazeno 1 - 6
of 6
pro vyhledávání: '"A V, Martynchyk"'
Publikováno v:
Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie; 2022, Vol. 35 Issue 6, p448-453, 6p
Publikováno v:
Likarska sprava. :9-19
Дифузна В-великоклітинна лімфома (ДВВКЛ) належить до потенційно виліковних захворювань. Проте група хворих на ДВВКЛ є дуже різнорідною
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7151fcd912eb400453d979b5deb345bd
https://doi.org/10.31640/ls-2017(1-2)02
https://doi.org/10.31640/ls-2017(1-2)02
Autor:
I. А. Kryachok, I. A. Stepanishyna, I. B. Titorenko, O. I. Novosad, K. S. Filonenko, A. V. Martynchyk, T. V. Kadnikova, O. M. Aleksik, Е. V. Kuschevyy, null I. V., K. O. Ulyanchenko, T. V. Skrypets
Publikováno v:
Likarska sprava. :16-22
Представлены данные литературы о диагностике и различных подходах к терапии первой линии первичной медиастинальной В-крупноклеточной
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79ecae18862628531474606ec88b2828
https://doi.org/10.31640/ls-2016(7-8)02
https://doi.org/10.31640/ls-2016(7-8)02
Autor:
O I, Novosad, I A, Kriachok, T V, Kadnikova, K S, Filonenko, I B, Tytorenko, A V, Martynchyk, O M, Aleksyk, Iu O, Gusachenko, I A, Filonenko
Publikováno v:
Likars'ka sprava. (3-4)
Achievements of world practice about development and prophilaxis of tromboembolic events (VTE) in cancer patients. Particular attention is paid to prevention of VTE in patients with multiply myeloma who receive chemotherapy with Thalidomide.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1b40352621b68886488611a730d83967
https://pubmed.ncbi.nlm.nih.gov/22416363
https://pubmed.ncbi.nlm.nih.gov/22416363
Autor:
I A, Kriachok, K S, Filonenko, G O, Gubareva, I B, Tytorenko, O I, Novosad, T V, Kadnikova, O M, Aleksik, A V, Martynchyk, É V, Kushchevyĭ, Ia V, Pastushenko, L B, Kutsenko
Publikováno v:
Likars'ka sprava. (1-2)
Management of non-Hodgkin's lymphomas (NHL) has been significantly changed during last 40 years from radiotherapy to modern polychemotherapy with application of monoclonal antibodies. A ten year experience of the treatment of patients with B-cell NHL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5e3fbb29f3400f9defaed08c2da871a
https://pubmed.ncbi.nlm.nih.gov/21954645
https://pubmed.ncbi.nlm.nih.gov/21954645
Autor:
H O, Hubareva, I A, Kriachok, I B, Tytorenko, O M, Aleksyk, O I, Novosad, T V, Kadnikova, A V, Martynchyk, Ia V, Pastushenko, K S, Filonenko, Ie V, Kushchevyĭ
Publikováno v:
Likars'ka sprava. (1-2)
The treatment of patients with refractory forms of Hodgkin's lymphomas in combination with chemo-radiotherapy is priority. Nevertheless, chemotherapy has to include multicomponent schemes and radiation therapy should be an addition and consolidative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c87d75a3b07ecdb8ae851ac011ff4c4c
https://pubmed.ncbi.nlm.nih.gov/20608037
https://pubmed.ncbi.nlm.nih.gov/20608037